Table 2 Drug loading and encapsulation efficiency of MPDA at different drug administration ratios
From: The subacute toxicity and underlying mechanisms of biomimetic mesoporous polydopamine nanoparticles
DOX : MPDA Dosing ratio | 1:1 | 1:2 | 1:4 |
|---|---|---|---|
EE | 79.53\(\pm\)1.24% | 88.63\(\pm\)2.59% | 98.99\(\pm\)0.53% |
DL | 55.16\(\pm\)4.62% | 37.05\(\pm\)2.31% | 24.27\(\pm\)0.23% |